表紙:敗血症診断の市場規模、シェア、動向分析:製品別(アッセイキット・試薬、血液培地)、技術別(マイクロバイオロジー、イムノアッセイ)、病原体別(細菌、真菌)のセグメント予測(2022年~2030年)
市場調査レポート
商品コード
1092735

敗血症診断の市場規模、シェア、動向分析:製品別(アッセイキット・試薬、血液培地)、技術別(マイクロバイオロジー、イムノアッセイ)、病原体別(細菌、真菌)のセグメント予測(2022年~2030年)

Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Blood Culture Media), By Technology (Microbiology, Immunoassays), By Pathogen (Bacterial, Fungal), And Segment Forecasts, 2022 - 2030

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 120 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
敗血症診断の市場規模、シェア、動向分析:製品別(アッセイキット・試薬、血液培地)、技術別(マイクロバイオロジー、イムノアッセイ)、病原体別(細菌、真菌)のセグメント予測(2022年~2030年)
出版日: 2022年05月30日
発行: Grand View Research, Inc.
ページ情報: 英文 120 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の敗血症診断の市場規模は、予測期間に9.6%のCAGRで拡大する見通しで、2030年までに14億米ドルに達すると予測されています。

敗血症の高い有病率、先進技術の診断システム導入、政府の取り組み拡大などが、予測期間中の市場成長を促進すると予想されます。

当レポートでは、世界の敗血症診断市場について調査し、市場の動向、セグメント・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 敗血症診断市場の変数、動向および範囲

  • 市場系統の見通し
  • 浸透と成長の見通しマッピング
  • 市場力学
  • 市場分析ツール

第4章 敗血症診断市場 - 競合分析

  • 主要市場参入企業別:最近の動向と影響分析
  • ベンダー情勢
  • 公開企業
  • 民間企業

第5章 敗血症診断市場の推計と動向分析:製品別

  • 定義と範囲
  • 市場シェア分析(2021年、2030年)
  • セグメントダッシュボード
  • 世界市場:製品別(2018年~2030年)
  • 市場規模・予測、動向分析(2018年~2030年)
    • 機器
    • 血液培地
    • アッセイキット・試薬

第6章 敗血症診断市場の推計と動向分析:技術別

  • 定義と範囲
  • 市場シェア分析(2021年、2030年)
  • セグメントダッシュボード
  • 世界市場:技術別(2018年~2030年)
  • 市場規模・予測、動向分析(2018年~2030年)
    • マイクロバイオロジー
    • 分子診断
    • イムノアッセイ
    • フローサイトメトリー

第7章 敗血症診断市場の推計と動向分析:病原体別

  • 定義と範囲
  • 市場シェア分析(2021年、2030年)
  • セグメントダッシュボード
  • 世界市場:病原体別(2018年~2030年)
  • 市場規模・予測、動向分析(2018年~2030年)
    • 細菌性敗血症
    • 真菌性敗血症
    • その他

第8章 敗血症診断市場の推計と動向分析:検査タイプ別

  • 定義と範囲
  • 市場シェア分析(2021年、2030年)
  • セグメントダッシュボード
  • 世界市場:検査タイプ別(2018年~2030年)
  • 市場規模・予測、動向分析(2018年~2030年)
    • ラボ検査
    • POC検査

第9章 敗血症診断市場の推計と動向分析:地域別

  • 地域市場のスナップショット
  • 地域市場シェアと主要企業(2021年)
  • 国別:市場シェア分析(2021年)
  • 要因別:SWOT分析
  • 市場規模と予測、動向分析(2018年~2030年)
    • 北米
    • 欧州
    • ラテンアメリカ
    • アジア太平洋
    • 中東・アフリカ

第10章 企業プロファイル

  • bioMerieux SA
  • Becton, Dickinson and Company (BD)
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche
  • Luminex Corporation
  • Danaher
  • Luminex Corporation
  • Bruker Corporation
  • Amara Health Analytics
  • Wolters Kluwer N.V.
  • Cerner Corporation
  • Epic Systems Corporation
  • McKesson Corporation
  • GE Healthcare
  • Koninklijke Philips N.V.
図表

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 4 North America sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 5 North America sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 6 North America sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 7 North America sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 8 North America sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 9 U.S. sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 11 U.S. sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 12 U.S. sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 13 U.S. sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 14 Canada sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 15 Canada sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 16 Canada sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 17 Canada sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 18 Canada sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 19 Europe sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 22 Europe sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 23 Europe sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 24 Europe sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 25 Germany sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 26 Germany sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 27 Germany sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 28 Germany sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 29 Germany sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 30 U.K. sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 31 U.K. sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 32 U.K. sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 33 U.K. sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 34 U.K. sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 35 France sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 36 France sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 37 France sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 38 France sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 39 France sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 40 Italy sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 41 Italy sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 42 Italy sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 43 Italy sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 44 Italy sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 45 Spain sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 46 Spain sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 47 Spain sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 48 Spain sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 49 Spain sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 50 Russia sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 51 Russia sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 52 Russia sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 53 Russia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 54 Russia sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 61 China sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 62 China sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 63 China sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 64 China sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 65 China sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 66 India sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 67 India sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 68 India sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 69 India sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 70 India sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 71 Australia sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 72 Australia sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 73 Australia sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 74 Australia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 75 Australia sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 76 Japan sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 77 Japan sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 78 Japan sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 79 Japan sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 80 Japan sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 81 South Korea sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 82 South Korea sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 83 South Korea sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 84 South Korea sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 85 South Korea sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 86 Singapore sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 87 Singapore sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 88 Singapore sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 89 Singapore sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 90 Singapore sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 91 Latin America sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 92 Latin America sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 93 Latin America sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 94 Latin America sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 95 Latin America sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 96 Latin America sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 97 Brazil sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 98 Brazil sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 99 Brazil sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 100 Brazil sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 101 Brazil sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 102 Mexico sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 103 Mexico sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 104 Mexico sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 105 Mexico sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 106 Mexico sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 107 Argentina sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 108 Argentina sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 109 Argentina sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 110 Argentina sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 111 Argentina sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 112 MEA sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 113 MEA sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 114 MEA sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 115 MEA sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 116 MEA sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 117 MEA sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 118 South Africa sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 119 South Africa sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 120 South Africa sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 121 South Africa sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 122 South Africa sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 123 Saudi Arabia sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 124 Saudi Arabia sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 125 Saudi Arabia sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 126 Saudi Arabia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 127 Saudi Arabia sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 128 UAE sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 129 UAE sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 130 UAE sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 131 UAE sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 132 UAE sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot, 2021 (USD Million)
  • Fig. 9 Sepsis diagnostics market segmentation
  • Fig. 10 Penetration & growth prospect mapping for product, 2021
  • Fig. 11 Penetration & growth prospect mapping for technology, 2021
  • Fig. 12 Penetration & growth prospect mapping for pathogen, 2021
  • Fig. 13 Penetration & growth prospect mapping for testing type, 2021
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Company/competition categorization (key innovators, market leaders, emerging players)
  • Fig. 17 Strategy framework
  • Fig. 18 Market participation categorization
  • Fig. 19 Company position analysis
  • Fig. 20 Sepsis diagnostics market: Product outlook and key takeaways
  • Fig. 21 Sepsis diagnostics market: Product movement analysis
  • Fig. 22 Instruments market, 2018 - 2030 (USD Million)
  • Fig. 23 Blood culture media market, 2018 - 2030 (USD Million)
  • Fig. 24 Assay kits & reagents market, 2018 - 2030 (USD Million)
  • Fig. 25 Sepsis diagnostics market: Technology outlook and key takeaways
  • Fig. 26 Sepsis diagnostics market: Technology movement analysis
  • Fig. 27 Microbiology market, 2018 - 2030 (USD Million)
  • Fig. 28 Molecular diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 29 Immunoassays market, 2018 - 2030 (USD Million)
  • Fig. 30 Flow cytometry market, 2018 - 2030 (USD Million)
  • Fig. 31 Sepsis diagnostics market: Pathogen outlook and key takeaways
  • Fig. 32 Sepsis diagnostics market: Pathogen movement analysis
  • Fig. 33 Bacterial sepsis market, 2018 - 2030 (USD Million)
  • Fig. 34 Gram-negative bacterial sepsis market, 2018 - 2030 (USD Million)
  • Fig. 35 Gram-positive bacterial sepsis market, 2018 - 2030 (USD Million)
  • Fig. 36 Fungal sepsis market, 2018 - 2030 (USD Million)
  • Fig. 37 Other pathogenic sepsis market, 2018 - 2030 (USD Million)
  • Fig. 38 Sepsis diagnostics market: Testing type outlook and key takeaways
  • Fig. 39 Sepsis diagnostics market: Testing type movement analysis
  • Fig. 40 Laboratory testing market, 2018 - 2030 (USD Million)
  • Fig. 41 Point-of-care testing market, 2018 - 2030 (USD Million)
  • Fig. 42 Sepsis diagnostics market: Regional outlook and key takeaways
  • Fig. 43 Sepsis diagnostics market: Regional movement analysis
  • Fig. 44 North America
  • Fig. 45 North America sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 U.S.
  • Fig. 47 U.S. sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Canada
  • Fig. 49 Canada sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Europe
  • Fig. 51 Europe sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Germany
  • Fig. 53 Germany sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 U.K.
  • Fig. 55 U.K. sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 France
  • Fig. 57 France sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Italy
  • Fig. 59 Italy sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Spain
  • Fig. 61 Spain sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Russia
  • Fig. 63 Russia sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific
  • Fig. 65 Asia Pacific sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Japan
  • Fig. 67 Japan sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 China
  • Fig. 69 China sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 India
  • Fig. 71 India sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 South Korea
  • Fig. 73 South Korea sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Australia
  • Fig. 75 Australia sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Singapore
  • Fig. 77 Singapore sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Latin America
  • Fig. 79 Latin America sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Brazil
  • Fig. 81 Brazil sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Mexico
  • Fig. 83 Mexico sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Argentina
  • Fig. 85 Argentina sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 MEA
  • Fig. 87 MEA sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 South Africa
  • Fig. 89 South Africa sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Saudi Arabia
  • Fig. 91 Saudi Arabia sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 UAE
  • Fig. 93 UAE sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-352-2

Sepsis Diagnostics Market Growth & Trends:

The global sepsis diagnostics market size is expected to reach USD 1.4 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.6% over the forecast period. The high prevalence of sepsis, the introduction of technologically advanced diagnostic systems, and increasing government initiatives are expected to propel market growth over the forecast period. Sepsis is a bloodstream disease that occurs as a result of a response to pathogenic microorganisms present in the blood. Patients suffering from this disease experience severe inflammation, which leads to prolonged hospitalization.

According to the WHO, around 30 million people are estimated to be affected by this disease every year.The NCBI stated that the largest number of this condition has been observed in the youngest and oldest age groups. Thus, there is a rising need for the early diagnosis of this disease. The WHO reported that every year, 1.2 million children and 3 million newborns are affected by this disease across the world. This has further boosted the demand for its diagnostic tools for quick results and improved patient outcomes. Increasing regulatory approval and the introduction of technologically advanced diagnostic solutions for sepsis are expected to facilitate market growth over the forecast period.

In May 2018, T2 Biosystems, Inc., a U.S.-based emerging diagnostic solutions company, received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens. The COVID-19 pandemic affected the growth of diagnostics products for sepsis in a moderately positive way. The worldwide spread of Coronavirus and the arising instances of sepsis among COVID-19 patients are probably going to expand the interest for fast detection, speeding up the use of instruments, reagents, and assay kits for recognition of sepsis. Pandemic-induced lockdown and other restrictions made individuals delay going through wellbeing checkups, influencing the number of tests performed and reagent deals.

The pandemic has featured the risk upon elders, who are more defenseless to complications, including intense respiratory distress condition, typically because of pneumonia, which builds the risk of creating sepsis. This has created a need for the early detection of sepsis among patients with COVID-19. Symptoms of sepsis, such as multiorgan injuries, develop in around 2.0 to 5.0% of COVID-19 cases 8 to 10 days post-hospitalization, based on the estimates of the Global Sepsis Alliance. To manage this situation, the Biomedical Advanced Research and Development Authority, in May 2020, extended its partnership with Beckman Coulter for the development of a digital algorithm to detect sepsis in patients with COVID-19.

Sepsis Diagnostics Market Report Highlights:

  • By product, blood culture media held the largest share in 2021 as it is the most accurate mode of testing for the diagnosis of this disease. It is also anticipated to witness the fastest CAGR over the forecast period owing to new product developments in this field
  • The microbiology technology segment had the largest share in 2021 and the molecular diagnostics segment is anticipated to exhibit a lucrative CAGR over the forecast period owing to its high sensitivity, accuracy, and less turnaround time
  • The bacterial pathogen segment held the largest revenue share in 2021 owing to the high prevalence of bacterial sepsis
  • The laboratory testing type segment dominated the market in 2021 and accounted for the maximum revenue share on account of the better accuracy of these tests
  • North America dominated the market in 2021 due to a favorable reimbursement scenario, the presence of established players, and high awareness about sepsis & its diagnosis
  • Middle East Africa is projected to witness a lucrative growth rate over the forecast period owing to the presence of a large target population in emerging economies, such as Algeria and Morocco

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation & scope
  • 1.2 Market definition
  • 1.3 Information procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information analysis
    • 1.4.1 Data analysis models
  • 1.5 Market formulation & data visualization
  • 1.6 Data validation & publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Sepsis Diagnostics Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Increase in the prevalence of sepsis
      • 3.3.1.2 Rise in the incidence of hospital-acquired infections
      • 3.3.1.3 Increase in the number of pneumonia cases
      • 3.3.1.4 Approval and launch of advanced sepsis diagnostic systems
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 High cost of automated diagnostic instruments
      • 3.3.2.2 Lack of awareness about sepsis
    • 3.3.3 Industry challenges
      • 3.3.3.1 Scientific and clinical challenges associated with sepsis
  • 3.4 Sepsis Diagnostics Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
      • 3.4.1.1 Supplier Power
      • 3.4.1.2 Buyer Power
      • 3.4.1.3 Substitution Threat
      • 3.4.1.4 Threat from new entrants
      • 3.4.1.5 Competitive Rivalry
    • 3.4.2 PESTEL Analysis
      • 3.4.2.1 Political Landscape
      • 3.4.2.2 Environmental Landscape
      • 3.4.2.3 Social landscape
      • 3.4.2.4 Technology landscape
      • 3.4.2.5 Legal Landscape
    • 3.4.3 Major deals and strategic alliances analysis
      • 3.4.3.1 Joint ventures
      • 3.4.3.2 Mergers and acquisitions
      • 3.4.3.3 Licensing and partnership
      • 3.4.3.4 Technology collaborations
      • 3.4.3.5 Strategic Divestments

Chapter 4 Sepsis Diagnostics Market - Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Vendor Landscape
    • 4.2.1 List of key distributors and channel partners
    • 4.2.2 Key company market share analysis, 2021
  • 4.3 Public Companies
    • 4.3.1 Company market position analysis
    • 4.3.2 Competitive dashboard analysis
  • 4.4 Private Companies
    • 4.4.1 List of key emerging companies
    • 4.4.2 Regional network map
    • 4.4.3 Company market position analysis

Chapter 5 Sepsis Diagnostics Market: Product Estimates And Trend Analysis

  • 5.1 Definition & Scope
  • 5.2 Product Market Share Analysis, 2021 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Sepsis Diagnostics Market, by Product, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Instruments
      • 5.5.1.1 Instruments Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 5.5.2 Blood Culture Media
      • 5.5.2.1 Blood Culture Media Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 5.5.3 Assay Kits and Reagents
      • 5.5.3.1 Assay Kits and Reagents Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 6 Sepsis Diagnostics Market: Technology Estimates And Trend Analysis

  • 6.1 Definition & Scope
  • 6.2 Technology Market Share Analysis, 2021 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global Sepsis Diagnostics Market, by Technology, 2018 to 2030
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.5.1 Microbiology
      • 6.5.1.1 Microbiology Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.2 Molecular Diagnostics
      • 6.5.2.1 Molecular Diagnostics Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.3 Immunoassays
      • 6.5.3.1 Immunoassays Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.4 Flow Cytometry
      • 6.5.4.1 Flow Cytometry Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 7 Sepsis Diagnostics Market: Pathogen Estimates And Trend Analysis

  • 7.1 Definition & Scope
  • 7.2 Pathogen Market Share Analysis, 2021 & 2030
  • 7.3 Segment Dashboard
  • 7.4 Global Sepsis Diagnostics Market, by Pathogen, 2018 to 2030
  • 7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 7.5.1 Bacterial Sepsis
      • 7.5.1.1 Bacterial Sepsis Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 7.5.1.2 Gram-positive Bacteria
      • 7.5.1.2.1 Gram-positive Bacteria Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 7.5.1.3 Gram-negative Bacteria
      • 7.5.1.3.1 Gram-negative Bacteria Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.2 Fungal Sepsis
      • 7.5.2.1 Fungal Sepsis Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.3 Others
      • 7.5.3.1 Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 8 Sepsis Diagnostics Market: Testing Type Estimates And Trend Analysis

  • 8.1 Definition & Scope
  • 8.2 Testing Type Market Share Analysis, 2021 & 2030
  • 8.3 Segment Dashboard
  • 8.4 Global Sepsis Diagnostics Market, by Testing Type, 2018 to 2030
  • 8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 8.5.1 Laboratory Testing
      • 8.5.1.1 Laboratory Testing Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 8.5.2 PoC Testing
      • 8.5.2.1 PoC Testing Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 9 Sepsis Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1 Regional Market Snapshot
  • 9.2 Regional Market Share and Leading Players, 2021
    • 9.2.1 North America
    • 9.2.2 Europe
    • 9.2.3 Latin America
    • 9.2.4 Asia Pacific
    • 9.2.5 Middle East & Africa
  • 9.3 Market Share Analysis by Country, 2021
    • 9.3.1 North America
      • 9.3.1.1 U.S.
      • 9.3.1.2 Canada
    • 9.3.2 Europe
      • 9.3.2.1 U.K.
      • 9.3.2.2 Germany
      • 9.3.2.3 Spain
      • 9.3.2.4 France
      • 9.3.2.5 Italy
      • 9.3.2.6 Russia
    • 9.3.3 Latin America
      • 9.3.3.1 Brazil
      • 9.3.3.2 Mexico
      • 9.3.3.3 Argentina
    • 9.3.4 Asia Pacific
      • 9.3.4.1 Japan
      • 9.3.4.2 China
      • 9.3.4.3 India
      • 9.3.4.4 South Korea
      • 9.3.4.5 Singapore
      • 9.3.4.6 Australia
    • 9.3.5 Middle East & Africa
      • 9.3.5.1 South Africa
      • 9.3.5.2 Saudi Arabia
      • 9.3.5.3 UAE
  • 9.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 9.4.1 North America
    • 9.4.2 Europe
    • 9.4.3 Latin America
    • 9.4.4 Asia Pacific
    • 9.4.5 Middle East & Africa
  • 9.5 Market Size & Forecasts, and Trend Analysis, 2018 to 2030
    • 9.5.1 North America
      • 9.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 9.5.1.2 U.S.
      • 9.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.1.2.2 U.S. Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.1.2.3 U.S. Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.1.2.4 U.S. Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.1.3 Canada
      • 9.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.1.3.2 Canada Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.1.3.3 Canada Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.1.3.4 Canada Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
    • 9.5.2 Europe
      • 9.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 9.5.2.2 U.K.
      • 9.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.2.2.2 U.K. Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.2.2.3 U.K. Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.2.2.4 U.K. Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.2.3 Germany
      • 9.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.2.3.2 Germany Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.2.3.3 Germany Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.2.3.4 Germany Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.2.4 Spain
      • 9.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.2.4.2 Spain Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.2.4.3 Spain Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.2.4.4 Spain Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.2.5 France
      • 9.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.2.5.2 France Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.2.5.3 France Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.2.5.4 France Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.2.6 Italy
      • 9.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.2.6.2 Italy Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.2.6.3 Italy Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.2.6.4 Italy Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.2.7 Russia
      • 9.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.2.7.2 Russia Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.2.7.3 Russia Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.2.7.4 Russia Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
    • 9.5.3 Latin America
      • 9.5.3.1 Latin America Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 9.5.3.2 Brazil
      • 9.5.3.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.3.2.2 Brazil Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.3.2.3 Brazil Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.3.2.4 Brazil Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.3.3 Mexico
      • 9.5.3.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.3.3.2 Mexico Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.3.3.3 Mexico Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.3.3.4 Mexico Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.3.4 Argentina
      • 9.5.3.4.1 Argentina Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.3.4.2 Argentina Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.3.4.3 Argentina Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.3.4.4 Argentina Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
    • 9.5.4 Asia Pacific
      • 9.5.4.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 9.5.4.2 Japan
      • 9.5.4.2.1 Japan Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.4.2.2 Japan Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.4.2.3 Japan Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.4.2.4 Japan Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.4.3 China
      • 9.5.4.3.1 China Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.4.3.2 China Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.4.3.3 China Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.4.3.4 China Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.4.4 India
      • 9.5.4.4.1 India Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.4.4.2 India Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.4.4.3 India Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.4.4.4 India Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.4.5 South Korea
      • 9.5.4.5.1 South Korea Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.4.5.2 South Korea Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.4.5.3 South Korea Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.4.5.4 South Korea Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.4.6 Singapore
      • 9.5.4.6.1 Singapore Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.4.6.2 Singapore Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.4.6.3 Singapore Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.4.6.4 Singapore Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.4.7 Australia
      • 9.5.4.7.1 Australia Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.4.7.2 Australia Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.4.7.3 Australia Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.4.7.3 Australia Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
    • 9.5.5 Middle East & Africa
      • 9.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 9.5.5.2 South Africa
      • 9.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.5.2.2 South Africa Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.5.2.3 South Africa Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.5.2.4 South Africa Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.5.3 Saudi Arabia
      • 9.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.5.3.2 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.5.3.3 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.5.3.4 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)
      • 9.5.5.4 UAE
      • 9.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
      • 9.5.5.4.2 UAE Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
      • 9.5.5.4.3 UAE Market Size & Forecasts and Trend Analysis, By Pathogen, 2018 to 2030 (USD Million)
      • 9.5.5.4.4 UAE Market Size & Forecasts and Trend Analysis, By Testing Type, 2018 to 2030 (USD Million)

Chapter 10 Company Profiles

  • 10.1 Company Profiles
    • 10.1.1 bioMerieux SA
      • 10.1.1.1 Company overview
      • 10.1.1.2 Financial Performance
      • 10.1.1.3 Product benchmarking
      • 10.1.1.4 Strategic initiatives
    • 10.1.2 Becton, Dickinson and Company (BD)
      • 10.1.2.1 Company overview
      • 10.1.2.2 Financial Performance
      • 10.1.2.3 Product benchmarking
      • 10.1.2.4 Strategic initiatives
    • 10.1.3 Thermo Fisher Scientific, Inc.
      • 10.1.3.1 Company overview
      • 10.1.3.2 Financial Performance
      • 10.1.3.3 Product benchmarking
      • 10.1.3.4 Strategic initiatives
    • 10.1.4 F. Hoffmann-La Roche
      • 10.1.4.1 Company overview
      • 10.1.4.2 Financial Performance
      • 10.1.4.3 Product benchmarking
      • 10.1.4.4 Strategic initiatives
    • 10.1.5 Luminex Corporation
      • 10.1.5.1 Company overview
      • 10.1.5.2 Financial Performance
      • 10.1.5.3 Product benchmarking
      • 10.1.5.4 Strategic initiatives
    • 10.1.6 Danaher
      • 10.1.6.1 Cepheid
      • 10.1.6.1.1 Company overview
      • 10.1.6.1.2 Financial Performance
      • 10.1.6.1.3 Product benchmarking
      • 10.1.6.1.4 Strategic initiatives
      • 10.1.6.2 Beckman Coulter, Inc.
      • 10.1.6.2.1 Company overview
      • 10.1.6.2.2 Financial Performance
      • 10.1.6.2.3 Product benchmarking
      • 10.1.6.2.4 Strategic initiatives
    • 10.1.7 Luminex Corporation
      • 10.1.7.1 Company overview
      • 10.1.7.2 Financial Performance
      • 10.1.7.3 Product benchmarking
      • 10.1.7.4 Strategic initiatives
    • 10.1.8 Bruker Corporation
      • 10.1.8.1 Company overview
      • 10.1.8.2 Financial Performance
      • 10.1.8.3 Product benchmarking
      • 10.1.8.4 Strategic initiatives
    • 10.1.9 Amara Health Analytics
      • 10.1.9.1 Company overview
      • 10.1.9.2 Financial Performance
      • 10.1.9.3 Product benchmarking
      • 10.1.9.4 Strategic initiatives
    • 10.1.10 Wolters Kluwer N.V.
      • 10.1.10.1 Company overview
      • 10.1.10.2 Financial Performance
      • 10.1.10.3 Product benchmarking
      • 10.1.10.4 Strategic initiatives
    • 10.1.11 Cerner Corporation
      • 10.1.11.1 Company overview
      • 10.1.11.2 Financial Performance
      • 10.1.11.3 Product benchmarking
      • 10.1.11.4 Strategic initiatives
    • 10.1.12 Epic Systems Corporation
      • 10.1.12.1 Company overview
      • 10.1.12.2 Financial Performance
      • 10.1.12.3 Product benchmarking
      • 10.1.12.4 Strategic initiatives
    • 10.1.13 McKesson Corporation
      • 10.1.13.1 Company overview
      • 10.1.13.2 Financial Performance
      • 10.1.13.3 Product benchmarking
      • 10.1.13.4 Strategic initiatives
    • 10.1.14 GE Healthcare
      • 10.1.14.1 Company overview
      • 10.1.14.2 Financial Performance
      • 10.1.14.3 Product benchmarking
      • 10.1.14.4 Strategic initiatives
    • 10.1.15 Koninklijke Philips N.V.
      • 10.1.15.1 Company overview
      • 10.1.15.2 Financial Performance
      • 10.1.15.3 Product benchmarking
      • 10.1.15.4 Strategic initiatives